Close Menu
June 02, 2020
Sponsored by
NanoString

The Need for Digital Spatial Profiling for Host-Pathogen Interaction: A York Perspective

GenomeWebinar

Director of the Bioscience Technology Facility, and Head of Imaging and Cytometry, Department of Biology, University of York

Core facilities support a broad range of scientific studies and must constantly integrate new technologies and analysis to underpin their users’ research. Areas for development include higher multiplex capabilities, greater quantification, correlation to other tools, as well as multi-omics. 

In this webinar, Peter O’Toole, Director of the University of York’s Bioscience Technology Facility, will share his experience integrating digital spatial profiling into the core. He will describe how this technology fits into the wider set of complementary platforms and techniques at the core, with the GeoMx DSP delivering high-plex, quantitative imaging for both protein and RNA studies.

Using the example of leshmaniasis, he will also talk about early successes using the DSP for developing a new understanding of host-pathogen interaction in specific tissue microenvironments. Future applications will support neuroscience, oncology, immunology, and infectious disease.   

Sponsored by

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
01
Sponsored by
Adaptive Biotechnologies

T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, and also support the development of antibodies by B cells. 

Oct
08
Sponsored by
Genecentric

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct
14
Sponsored by
Inivata

Circulating tumor DNA (ctDNA) can allow clinicians and researchers to better understand which patients are at high risk of recurrence and should be offered intensified chemotherapy or selected for clinical trials.